EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+37.13%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$199M
AUM Growth
+$199M
(-2.4%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-6.18%
Top 10 Holdings %
Top 10 Hldgs %
61.97%
Holding
84
New
13
Increased
17
Reduced
19
Closed
23
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$13.3M |
| 2 |
Merck
MRK
|
$10.6M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$8.72M |
| 4 |
Danaher
DHR
|
$3.87M |
| 5 |
Sanofi
SNY
|
$3.03M |
Top Sells
| 1 |
QCP
Quality Care Properties, Inc.
QCP
|
$23.1M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$7.94M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$6.54M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$6.25M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$3.78M |
Sector Composition
| 1 | Healthcare | 79.94% |
| 2 | Industrials | 8.6% |
| 3 | Communication Services | 0.58% |
| 4 | Real Estate | 0.46% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iRadimed
IRMD
$898M
| – | – |
-17,608
| Closed | -$365K |
|
77
Immunic
IMUX
$79.4M
| – | – |
0
| – | – |
|
78
Haemonetics
HAE
$2.57B
| – | – |
-14,646
| Closed | -$1.31M |
|
79
Galmed Pharmaceuticals
GLMD
$7.07M
| – | – |
-10,000
| Closed | -$119K |
|
80
eHealth
EHTH
$126M
| – | – |
-56,546
| Closed | -$1.25M |
|
|
CLLS
81
Cellectis
CLLS
$260M
| – | – |
-30,000
| Closed | -$849K |
|
|
82
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-84,257
| Closed | -$7.94M |
|
|
83
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-63,493
| Closed | -$6.25M |
|
84
Arbutus Biopharma
ABUS
$753M
| – | – |
-97,495
| Closed | -$712K |
|